(2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide

C139H167N17O25S — CID 159725335

IUPAC(2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide
SMILESO=C(NCc1ccc(OC2CCCC2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCC2CCCC2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCCC2CCCC2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCc2cccnc2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCc2csc(-c3ccccc3)n2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1
InChIInChI=1S/C31H32N4O5S.C28H37N3O5.C27H30N4O5.C27H35N3O5.C26H33N3O5/c36-27(28(37)31(39)35-17-15-34(16-18-35)25-9-5-2-6-10-25)29(38)32-19-22-11-13-26(14-12-22)40-20-24-21-41-30(33-24)23-7-3-1-4-8-23;32-25(26(33)28(35)31-17-15-30(16-18-31)23-8-2-1-3-9-23)27(34)29-20-22-10-12-24(13-11-22)36-19-14-21-6-4-5-7-21;32-24(25(33)27(35)31-15-13-30(14-16-31)22-6-2-1-3-7-22)26(34)29-18-20-8-10-23(11-9-20)36-19-21-5-4-12-28-17-21;31-24(25(32)27(34)30-16-14-29(15-17-30)22-8-2-1-3-9-22)26(33)28-18-20-10-12-23(13-11-20)35-19-21-6-4-5-7-21;30-23(24(31)26(33)29-16-14-28(15-17-29)20-6-2-1-3-7-20)25(32)27-18-19-10-12-22(13-11-19)34-21-8-4-5-9-21/h1-14,21,27-28,36-37H,15-20H2,(H,32,38);1-3,8-13,21,25-26,32-33H,4-7,14-20H2,(H,29,34);1-12,17,24-25,32-33H,13-16,18-19H2,(H,29,34);1-3,8-13,21,24-25,31-32H,4-7,14-19H2,(H,28,33);1-3,6-7,10-13,21,23-24,30-31H,4-5,8-9,14-18H2,(H,27,32)/t27-,28-;25-,26-;2*24-,25-;23-,24-/m11111/s1
InChIKeyNAODKHZSIUKIMA-BWYQZKQFSA-N
MW2508.03 g/mol
LogP10.39
Rot. Bonds46

About (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide

(2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide (PubChem CID 159725335) has the molecular formula C139H167N17O25S and a molecular weight of 2508.03 g/mol. Its IUPAC name is (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide.

Molecular Properties

Compound Name(2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide
PubChem CID159725335
Molecular FormulaC139H167N17O25S
Molecular Weight2508.03 g/mol
Exact Mass2506.20
IUPAC Name(2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide
SMILESO=C(NCc1ccc(OC2CCCC2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCC2CCCC2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCCC2CCCC2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCc2cccnc2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCc2csc(-c3ccccc3)n2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1
InChIInChI=1S/C31H32N4O5S.C28H37N3O5.C27H30N4O5.C27H35N3O5.C26H33N3O5/c36-27(28(37)31(39)35-17-15-34(16-18-35)25-9-5-2-6-10-25)29(38)32-19-22-11-13-26(14-12-22)40-20-24-21-41-30(33-24)23-7-3-1-4-8-23;32-25(26(33)28(35)31-17-15-30(16-18-31)23-8-2-1-3-9-23)27(34)29-20-22-10-12-24(13-11-22)36-19-14-21-6-4-5-7-21;32-24(25(33)27(35)31-15-13-30(14-16-31)22-6-2-1-3-7-22)26(34)29-18-20-8-10-23(11-9-20)36-19-21-5-4-12-28-17-21;31-24(25(32)27(34)30-16-14-29(15-17-30)22-8-2-1-3-9-22)26(33)28-18-20-10-12-23(13-11-20)35-19-21-6-4-5-7-21;30-23(24(31)26(33)29-16-14-28(15-17-29)20-6-2-1-3-7-20)25(32)27-18-19-10-12-22(13-11-19)34-21-8-4-5-9-21/h1-14,21,27-28,36-37H,15-20H2,(H,32,38);1-3,8-13,21,25-26,32-33H,4-7,14-20H2,(H,29,34);1-12,17,24-25,32-33H,13-16,18-19H2,(H,29,34);1-3,8-13,21,24-25,31-32H,4-7,14-19H2,(H,28,33);1-3,6-7,10-13,21,23-24,30-31H,4-5,8-9,14-18H2,(H,27,32)/t27-,28-;25-,26-;2*24-,25-;23-,24-/m11111/s1
InChIKeyNAODKHZSIUKIMA-BWYQZKQFSA-N
XLogP10.39
TPSA537.48 Ų
H-Bond Donors15
H-Bond Acceptors33
Rotatable Bonds46
Heavy Atoms182
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002508.03
LogP ≤ 510.39
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1033

Analyze (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(2R,3R)-2,3-dihydroxy-N-[[3-[(3-methylphenyl)methoxy]phenyl]methyl]-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide
CID 59134471
2-cyclohexyloxy-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]acetamide
CID 55840932
4-phenyl-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]benzamide
CID 46476162
N-[2-oxo-2-[4-(4-phenylmethoxyphenyl)piperazin-1-yl]ethyl]pyridine-3-carboxamide
CID 143955756
N-[(4-chlorophenyl)methyl]-2,3-dihydroxy-4-[4-(4-methoxyphenyl)piperazin-1-yl]-4-oxobutanamide
CID 58922982
3-cyclopentyl-1-[4-[4-(pyridin-3-ylmethoxy)benzoyl]piperazin-1-yl]propan-1-one
CID 30854834
1-acetyl-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]piperidine-3-carboxamide
CID 42961707
2-[2-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methoxy]phenyl]acetic acid
CID 68884558
3-phenoxy-N-[2-(2-pyridin-3-yl-1,3-thiazol-4-yl)ethyl]propanamide
CID 112500659
3-[1-(3-phenoxypropanoyl)piperidin-4-yl]-N-(pyridin-3-ylmethyl)propanamide
CID 42516784
1-(2-cyclopentylethyl)-3-[(2-phenyl-1,3-thiazol-4-yl)methyl]urea
CID 86960431
(2R)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]oxolane-2-carboxamide
CID 51725557

Frequently Asked Questions

What is the IUPAC name of (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide?
The IUPAC name of (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide (CID 159725335) is (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide.
What is the SMILES notation for (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide?
The canonical SMILES for (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide is O=C(NCc1ccc(OC2CCCC2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCC2CCCC2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCCC2CCCC2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCc2cccnc2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.O=C(NCc1ccc(OCc2csc(-c3ccccc3)n2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCN(c2ccccc2)CC1.
What is the InChIKey of (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide?
The InChIKey is NAODKHZSIUKIMA-BWYQZKQFSA-N. The full InChI is InChI=1S/C31H32N4O5S.C28H37N3O5.C27H30N4O5.C27H35N3O5.C26H33N3O5/c36-27(28(37)31(39)35-17-15-34(16-18-35)25-9-5-2-6-10-25)29(38)32-19-22-11-13-26(14-12-22)40-20-24-21-41-30(33-24)23-7-3-1-4-8-23;32-25(26(33)28(35)31-17-15-30(16-18-31)23-8-2-1-3-9-23)27(34)29-20-22-10-12-24(13-11-22)36-19-14-21-6-4-5-7-21;32-24(25(33)27(35)31-15-13-30(14-16-31)22-6-2-1-3-7-22)26(34)29-18-20-8-10-23(11-9-20)36-19-21-5-4-12-28-17-21;31-24(25(32)27(34)30-16-14-29(15-17-30)22-8-2-1-3-9-22)26(33)28-18-20-10-12-23(13-11-20)35-19-21-6-4-5-7-21;30-23(24(31)26(33)29-16-14-28(15-17-29)20-6-2-1-3-7-20)25(32)27-18-19-10-12-22(13-11-19)34-21-8-4-5-9-21/h1-14,21,27-28,36-37H,15-20H2,(H,32,38);1-3,8-13,21,25-26,32-33H,4-7,14-20H2,(H,29,34);1-12,17,24-25,32-33H,13-16,18-19H2,(H,29,34);1-3,8-13,21,24-25,31-32H,4-7,14-19H2,(H,28,33);1-3,6-7,10-13,21,23-24,30-31H,4-5,8-9,14-18H2,(H,27,32)/t27-,28-;25-,26-;2*24-,25-;23-,24-/m11111/s1.
What are the key properties of (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide?
(2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide has a molecular weight of 2508.03 g/mol, XLogP of 10.39, 46 rotatable bonds, 15 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R)-N-[[4-(2-cyclopentylethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[[4-(cyclopentylmethoxy)phenyl]methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-N-[(4-cyclopentyloxyphenyl)methyl]-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-(4-phenylpiperazin-1-yl)-N-[[4-(pyridin-3-ylmethoxy)phenyl]methyl]butanamide is sourced from PubChem (CID 159725335), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).